IgA2 anti-dsDNA | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

19,814 results for “IgA2 anti-dsDNA”

Trials

View all 10119 →

Measurement of Anti-dsDNA by Both CLIFT & ELISA

100 participants · First posted Oct 6, 2017

Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation

20 participants · First posted Apr 14, 2023

Not yet recruiting

ITMCTR1900002801

Clinical study on anti-aging effect of invigorating spleen and tonifying kidney combined with NK cells

Drugs

View all 3715 →

anti-LAG-3/anti-TIGIT mAb

anti-viral compound

anti-CD3/anti-EpCAM bispecific T-cell engager

Organizations

View all 78 →

Novel Anti-Infective Technologies, LLC

AiCuris Anti-Infective Cures AG

Germany

AGENCE REGIONALE DE SANTE DE LA REUNION

Reunion

News

View all 5902 →

Novel Blood Test Could Guide Precision Treatment for Resistant Lupus with Rituximab-Belimumab Combination

Therapeutic Activation of the cGAS-STING Pathway: Emerging Strategies for Antitumor Immunotherapy and Antiviral Defense

2D4 Monoclonal Antibody Shows Promise in Treating Systemic Lupus Erythematosus by Targeting CD132

Page 1 of 1982